Investors
ImmunoPrecise’s proprietary technologies and products are positioned on the leading edge of antibody development, innovating our industry as a single source provider of the full complement of antibody discovery platforms. As an investor in ImmunoPrecise Antibodies, you’re joining us at the forefront of new, exciting, and valuable advancements in next-generation antibody discovery.
ImmunoPrecise Antibodies Ltd. Stock Information
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News Releases page.
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News Releases page.
For more information, please review our Stock Quotes and Charts, Investor Presentation or visit our News & Releases page.
Investor Relations
For investor inquiries please contact:
LifeSci Advisors
John Mullaly
jmullaly@lifesciadvisors.com
Financial Statements
Please find our financials on Sedar in English and Français.
Analyst Coverage
Download Industrielle Alliance Report
Chelsea Stellick
+1 (403) 705 4982
chelsea.stellick@iagto.ca
ImmunoPrecise Newsletter
Check out our most recent blog post:Understanding the Chain of Infection
Earnings Call
The Company held an earnings conference call via webcast on September 9th, 2021. View a recording of the earnings call or view a transcript of the earnings call
Sign Up for
Email Alerts
Enter your email to receive financial information by email.